People with a rare genetic form of ALS may benefit from extended use of an investigational drug, a new study shows. The medication, tofersen, benefited patients with mutations of the gene SOD1. These mutations create a misfolded version of a protein, which leads to amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease. In a… read on > read on >







